Risk management plans – one year on from the EMEA guidelines

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1130, 2006-01, pp. : 3-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Risk Management Plans: One Year on from the EMEA Guidelines

By Stather Rosie  

International Journal of Pharmaceutical Medicine, Vol. 20, Iss. 6, 2006-01 ,pp. : 385-387

Adis International

Access to resources Recommend Favorite

Pharmacovigilance during the Pre-Approval Phases: An Evolving Pharmaceutical Industry Model In Response To ICH E2E, CIOMS VI, FDA and EMEA/CHMP Risk-Management Guidelines

By Hartford Craig G.  

Drug Safety, Vol. 29, Iss. 8, 2006-01 ,pp. : 657-673

Adis International

Access to resources Recommend Favorite

Infliximab: safety update from EMEA

By  

Inpharma, Vol. 1, Iss. 1324, 2002-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

EMEA finds DVT risk with COCs is less than during pregnancy

By  

Inpharma, Vol. 1, Iss. 1308, 2001-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Incremental 1-Year Medical Resource Utilization and Costs for Patients with Herpes Zoster from a Set of US Health Plans

By White Ronald R.  

PharmacoEconomics, Vol. 27, Iss. 9, 2009-09 ,pp. : 781-792

Adis International

Access to resources Recommend Favorite